Antimicrobial Resistance
The AMR laboratory is dedicated to understanding the fundamental principles involved in the acquisition of antimicrobial resistance determinants and their dissemination among clinically relevant pathogenic bacteria. We apply this knowledge to develop tools for rapid, point-of-care diagnostics to support bedside treatment of drug-resistant bacterial infections.
Our approach is multidisciplinary and collaborative, encompassing wet lab research, whole genome sequencing, Artificial Intelligence (AI), Machine Learning (ML), and biostatistical tools to understand the emergence of antimicrobial resistance. Furthermore, we are developing prediction models for the rapid diagnosis and prediction of bacterial infections.
Additionally, we have a state-of-the-art AMR biorepository with 4000 clinically isolated bacterial pathogens and a dedicated cell culture facility to support host-pathogen interaction studies. Our research is supported by national and international collaborations with academic institutions, research institutes, hospitals, and industries.